Further exploration of the interaction between CD4+FOXP3+ T cells and CD8+ T cells may improve our understanding of tumor‐specific T‐cell activity in the tumor microenvironment, with potential impact on the development of immune‐modulatory therapies. Here, CD8A is linked to neoplasm.